SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-23-008926
Filing Date
2023-03-22
Accepted
2023-03-23 13:41:44
Documents
11
Effectiveness Date
2023-03-22

Document Format Files

Seq Description Document Type Size
1 S-8 s-82022inducementawards.htm S-8 87850
2 EX-FILING FEES forms-8feetableex107.htm EX-FILING FEES 2244
3 EX-5.1 ex51arrowhead-formsx8opi.htm EX-5.1 5020
4 EX-23.1 ex231rsj-arrowheadpharma.htm EX-23.1 1116
5 EX-23.2 ex232arrowhead-formsx8co.htm EX-23.2 5022
6 ex231rsj-arrowheadpharma001.jpg GRAPHIC 71081
7 ex232arrowhead-formsx8co001.jpg GRAPHIC 203396
8 ex232arrowhead-formsx8co002.jpg GRAPHIC 116944
9 ex51arrowhead-formsx8opi001.jpg GRAPHIC 203396
10 ex51arrowhead-formsx8opi002.jpg GRAPHIC 116944
11 forms-8feetableex107001.jpg GRAPHIC 130949
  Complete submission text file 0001628280-23-008926.txt   1263741
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-270779 | Film No.: 23755538
SIC: 2834 Pharmaceutical Preparations